NEUROGENE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.96 USD | +0.30% |
|
-1.74% | +54.59% |
| 03-22 | North American Morning Briefing : Stocks Struggle After New Records | DJ |
| 03-21 | William Blair Initiates Neurogene With Outperform Rating | MT |
Chart calendar Neurogene Inc.
fd1cff8eed6a5b6b1c8.Utn8Ol09_LQqj0pqmHzk1TgDi7_-KTU8UI0zbcLJVbQ.ELWyAy58i8F52DkFzRSwsEFu-_i3bFRKHf9GN7uLHoIDnstUEw6uwRz9Ew~e3248ae36ca43679034f22594eb9c3a1
Upcoming events on Neurogene Inc.
Past events on Neurogene Inc.
| 2024-03-20 09:30 | Stifel CNS Day |
| 2024-03-18 16:14 | Q4 2023 Earnings Release |
| 2024-03-10 | Leerink Partners Global Biopharma Conference |
| 2024-03-05 10:30 | TD Cowen Health Care Conference |
| 2023-07-18 08:30 | Neoleukin Therapeutics, Inc. and Neurogene Inc. Merger Call |
| 2023-06-08 16:30 | Annual General Meeting |
| 2023-05-09 15:42 | Q1 2023 Earnings Release |
| 2022-12-12 12:45 | American Society of Hematology Meeting - Publication Number: 684 |
| 2022-11-14 16:03 | Q3 2022 Earnings Release |
| 2022-08-10 13:00 | Canaccord Growth Conference |
| 2022-08-09 16:30 | Interim 2022 Earnings Call |
| 2022-08-09 16:02 | Interim 2022 Earnings Release |
| 2022-05-25 12:30 | H.C. Wainwright Global Life Sciences Investment Conference |
| 2022-05-12 16:30 | Annual General Meeting |
| 2022-05-11 16:20 | Bank of America Healthcare Conference |
| 2022-05-09 16:05 | Q1 2022 Earnings Release |
| 2022-04-14 12:00 | Canaccord Horizons in Oncology Virtual Conference |
| 2022-04-13 10:00 | American Association of Cancer Research Meeting - Abstract No 4227 |
| 2022-04-13 10:00 | American Association of Cancer Research Meeting - Abstract No CT250 |
| 2022-04-11 14:30 | American Association of Cancer Research Meeting - Abstract No 2067 |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -55,6 -56,3 1.33% | -65,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -36,3 -53,6 32.24% | -59,2 |
|
Net income Million USD | Released Forecast Spread | -55,2 | -36,3 -53,9 32.58% | -66,9 |
|
EPS USD | Released Forecast Spread | -10,6 | -7,80 -5,58 -39.84% | -3,62 |
| Announcement Date | 08/11/23 | 18/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -14,7 -15,5 4.64% | -15,3 | -15,9 | -16,6 | -17,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 2,38 -14,9 116% | -13,8 | -14,4 | -15,1 | -15,9 |
|
Net income Million USD | Released Forecast Spread | 2,38 -15,1 115.75% | -17,1 | -15,7 | -16,7 | -17,7 |
|
EPS USD | Released Forecast Spread | -1,17 | -1,00 | -0,91 | -0,95 | -0,86 |
| Announcement Date | 18/03/24 | - | - | - | - |
| Today 16:05 | QIAGEN N.V.: Q1 2024 Earnings Release |
| 2024-04-29 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-05-01 06:30 | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 06:30 | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 2024-05-01 07:00 | ALKERMES PLC: Q1 2024 Earnings Release |
| 2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Neurogene Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NGNE Stock
- Calendar Neurogene Inc.
